58th Annual Denver TB Course (Online Series)

58th Annual Denver TB Course (Online Series)

- Add to Calendar

View full list of Professional Education courses.

Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.

The 58th Annual Denver TB Course (Online Series) provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.

Course Highlights:

  • Epidemiology of tuberculosis

  • Transmission and pathogenesis

  • Diagnosis and treatment of tuberculosis including MDR/XDR-TB

  • Diagnosis and treatment of latent tuberculosis infection

  • Emphasis on vulnerable populations such as pediatric and HIV co-infection

  • Interactive Contact Investigation Workshop

Learning Objectives:

  • Discuss the epidemiological features which are associated with increased risk for tuberculosis.

  • Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.

  • Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.

  • Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the pharmacokinetics and potential toxicities of that regimen.

  • Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.

The 58th Annual TB Course will have weekly virtual presentations each Thursday from 4:00 pm - 5:30 pm MT led by expert faculty from April 14 – May 19, 2022. Recordings of presentations will be available for registered attendees.

2022 Topics and Speakers:

Thursday, April 14, 2022 4:00 - 5:30 pm MT 

Randall Reves, MD, MSc
Professor, Infectious Diseases and Epidemiology 
University of Colorado Denver School of Medicine
University of Colorado School of Public Health

Radiographic Presentation
Tilman L. Koelsch, MD
Assistant Professor
Department of Radiology
National Jewish Health

Thursday, April 21, 2022 4:00 - 5:30 pm MT
Laboratory Services
Reeti Khare, PhD, D(ABMM)
Director, Infectious Disease Laboratory
Advanced Diagnostic Laboratories
National Jewish Health
Diagnosis of LTBI
Robert Belknap, MD
Medical Director, Denver Metro TB Control Program
Associate Professor, Division of Infectious Diseases
Denver Health and University of Colorado

Thursday, April 28, 2022 4:00 - 5:30 pm MT 
Treatment of LTBI
Jared J. Eddy, MD, MPhil
Assistant Professor
Director of Infection Prevention & Antimicrobial Stewardship
Division of Mycobacterial & Respiratory Infections
Department of Medicine
National Jewish Health
  Treatment of Drug Susceptible TB
David E. Griffith, MD
Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health

Thursday, May 5, 2022 4:00 - 5:30 pm MT
Treatment of Drug-Resistant TB
Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor of Medicine, National Jewish Health 
University of Colorado Denver
Monitoring and Management of Side Effects
Shannon H. Kasperbauer, MD
Associate Professor of Medicine 
Division of Mycobacterial and Respiratory Infections  
National Jewish Health  
University of Colorado Health Sciences Center

Thursday, May 12, 2022 4:00 - 5:30 pm MT 
TB and HIV Co-infection
Michelle K. Haas, MD
Associate Director, Denver Metro TB Program at Denver Public Health
Assistant Professor, Division of Infectious Diseases 
University of Colorado Anschutz Medical Campus
Pediatric TB
James Gaensbauer, MD, MScPH
Pediatric Infectious Disease Specialist
Children's Center
Pediatric and Adolescent Medicine
Mayo Clinic

Thursday, May 19, 2022 4:00 - 5:30 pm MT
Contact Investigation Workshop with Q&A discussion
Robert Belknap, MD
Medical Director, Denver Metro TB Control Program
Associate Professor, Division of Infectious Diseases
Denver Health and University of Colorado

Registration Fees:

$250 General
$150 Military, Fellow and Resident*
National Jewish Health Staff - Please contact ProEd@njhealth.org to register.

*Verification of Fellowship Status Form (required)

To pay now, please fill out the registration form below. To make payment arrangements, please contact ProEd@njhealth.org.

If you are having problems registering, please call 800.844.2305 or 303.398.1000 or email ProEd@njhealth.org.

* Indicates required field

Contact Information

Additional Information


Registration Fee

For other payment arrangements, please contact ProEd@njhealth.org.

Accreditation and Designation Statements

Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 9.0 contact hours.

Registered nurses will receive a separate certificate for each session of the course. You must view the full session to earn credit; partial credit will not be awarded.